The poor diagnostic performance of prostate specific antigen (PSA) testing and the cancer agnostic nature of conventional Trans Rectal Ultrasound (TRUS) guided biopsies have led to a long‐standing debate about prostate cancer (PCa) diagnosis.1, 2. This evidence concerns the gene KLK3 and prostate carcinoma.